Stevard LLC’s AstraZeneca AZN Stock Holding History

Stevard LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$301K	Hold	2,295	–	–	1.12%	20
2024 Q3	$358K	Sell	2,295 -1,329	-37%	-$215K	1.46%	17
2024 Q2	$565K	Hold	3,624	–	–	0.49%	32
2024 Q1	$491K	Hold	3,624	–	–	0.44%	33
2023 Q4	$488K	Hold	3,624	–	–	0.48%	31
2023 Q3	$491K	Hold	3,624	–	–	0.5%	27
2023 Q2	$519K	Hold	3,624	–	–	0.49%	27
2023 Q1	$503K	Hold	3,624	–	–	0.47%	28
2022 Q4	$491K	Hold	3,624	–	–	0.42%	30
2022 Q3	$397K	Buy	+3,624	New	+$460K	0.37%	37
2022 Q1	$481K	Hold	3,624	–	–	0.37%	36
2021 Q4	$422K	Hold	3,624	–	–	0.3%	39
2021 Q3	$435K	Hold	3,624	–	–	0.34%	37
2021 Q2	$434K	Hold	3,624	–	–	0.33%	39
2021 Q1	$360K	Sell	3,624 -2,160	-37%	-$217K	0.3%	39
2020 Q4	$578K	Hold	5,784	–	–	0.2%	42
2020 Q3	$634K	Hold	5,784	–	–	0.26%	56
2020 Q2	$612K	Buy	5,784 +1,994	+53%	+$206K	0.31%	47
2020 Q1	$338K	Hold	3,790	–	–	0.22%	39
2019 Q4	$378K	Buy	+3,790	New	+$357K	0.24%	41

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Stevard LLC's AZN Position: Q4 2024 in Review

Stevard LLC held its AstraZeneca (AZN) position steady in Q4 2024 at 2,295 shares worth $301K. The position accounts for 1.12% of the portfolio, ranked #20.

Stevard LLC first reported a position in AZN in Q4 2019 and has held it in 20 quarters since. The position peaked at $634K in Q3 2020. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

Stevard LLC held 2,295 shares of AstraZeneca worth $301K as of Q4 2024.
Stevard LLC left its AstraZeneca share count unchanged in Q4 2024.
AstraZeneca made up 1.12% of Stevard LLC's portfolio in Q4 2024, its #20 holding.
Stevard LLC first reported a position in AstraZeneca in Q4 2019 and has held it in 20 quarters since.
Stevard LLC's AstraZeneca position peaked at $634K in Q3 2020.
1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Stevard LLC's 13F filing for Q4 2024, filed 13 Feb 2025.